​
​

Mesa Laboratories (MLAB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Mesa Laboratories Revenue Highlights

0

Latest Revenue (Q)

$58.17M

Main Segment (Y)

Sterilization and Disinfection Control

Main Geography (Y)

UNITED STATES

Mesa Laboratories Revenue by Period

Mesa Laboratories Revenue by Year

DateRevenueChange
2024-03-31--100.00%
2023-03-31-18.85%
2022-03-31-37.63%
2021-03-31-13.81%
2020-03-31-14.11%
2019-03-31-7.23%
2018-03-31-2.68%
2017-03-31-10.64%
2016-03-31-18.69%
2015-03-31-35.29%
2014-03-31-13.54%
2013-03-31-17.21%
2012-03-31-20.68%
2011-03-31-49.69%
2010-03-31-1.82%
2009-03-31-10.11%
2008-03-31-13.43%
2007-03-31-48.86%
2006-03-31-15.36%
2005-03-31-10.03%
2004-03-31-0.49%
2003-03-31-0.42%
2002-03-31--0.62%
2001-03-31-5.14%
2000-03-31-6.86%
1999-03-31-2.53%
1998-03-31-1.28%
1997-03-31--3.70%
1996-03-31-22.73%
1995-03-31-6.45%
1994-03-31--

Mesa Laboratories generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Mesa Laboratories Revenue by Quarter

DateRevenueChange
2024-06-30--1.25%
2024-03-31-10.16%
2023-12-31-0.58%
2023-09-30-4.98%
2023-06-30--8.90%
2023-03-31-2.40%
2022-12-31--7.60%
2022-09-30-16.44%
2022-06-30--14.31%
2022-03-31-7.65%
2021-12-31-52.61%
2021-09-30-2.63%
2021-06-30--8.02%
2021-03-31-11.10%
2020-12-31-7.26%
2020-09-30-6.41%
2020-06-30--12.47%
2020-03-31-8.07%
2019-12-31-23.96%
2019-09-30--2.86%
2019-06-30--0.60%
2019-03-31--0.88%
2018-12-31-7.31%
2018-09-30--1.10%
2018-06-30--6.47%
2018-03-31-13.56%
2017-12-31-3.12%
2017-09-30-1.24%
2017-06-30--6.69%
2017-03-31-1.91%
2016-12-31--2.32%
2016-09-30-15.61%
2016-06-30--14.90%
2016-03-31-24.60%
2015-12-31--8.56%
2015-09-30-19.93%
2015-06-30--2.17%
2015-03-31-4.09%
2014-12-31--3.83%
2014-09-30-13.05%
2014-06-30-4.37%
2014-03-31-19.81%
2013-12-31-3.47%
2013-09-30-13.00%
2013-06-30--12.41%
2013-03-31-12.74%
2012-12-31--2.95%
2012-09-30-10.86%
2012-06-30--13.29%
2012-03-31-31.53%
2011-12-31--0.34%
2011-09-30-4.53%
2011-06-30--10.81%
2011-03-31-30.23%
2010-12-31--1.32%
2010-09-30-4.01%
2010-06-30-19.72%
2010-03-31-17.09%
2009-12-31--1.65%
2009-09-30-8.64%
2009-06-30--8.93%
2009-03-31-2.40%
2008-12-31--6.02%
2008-09-30-12.37%
2008-06-30--12.71%
2008-03-31--

Mesa Laboratories generated $58.17M in revenue during Q1 2025, up -1.25% compared to the previous quarter, and up 104.64% compared to the same period a year ago.

Mesa Laboratories Revenue Breakdown

Mesa Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMar 24Mar 23Mar 22Mar 21Mar 20
Clinical Genomics-----
Calibration Solutions-----
Sterilization and Disinfection Control-----
Biopharmaceutical Development-----
Product-----
Service-----

Mesa Laboratories's latest annual revenue breakdown by segment (product or service), as of Mar 24: Sterilization and Disinfection Control (34.75%), Clinical Genomics (24.33%), Calibration Solutions (22.09%), and Biopharmaceutical Development (18.83%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Dec 19Sep 19Jun 19Dec 18
Product--------------------
Calibration Solutions--------------------
Sterilization and Disinfection Control--------------------
Clinical Genomics--------------------
Biopharmaceutical Development--------------------
Continuous Monitoring--------------------
Instruments--------------------
Cold Chain Monitoring--------------------
Sterilzation and Disinfection Control--------------------
Cold Chain Packaging--------------------

Mesa Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (100.00%).

Mesa Laboratories Revenue Breakdown by Country

Annual Revenue by Country

CountryMar 24Mar 23Mar 22Mar 21Mar 20
Other-----
CHINA-----
UNITED STATES-----
Non-US-----
Product-----

Mesa Laboratories's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (49.21%), Other (39.25%), and CHINA (11.53%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jun 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Other--------------------
UNITED STATES--------------------
CHINA--------------------
Non-US--------------------

Mesa Laboratories's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (48.55%), Other (38.67%), and CHINA (12.78%).

Mesa Laboratories Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
FTVFortive--
STSensata Technologies--
VNTVontier--
ITRIItron--
ESEESCO--
NOVTNovanta--
BMIBadger Meter--
COHRCoherent--
VPGVishay Precision Group--
FCUVFocus Universal--
MLABMesa Laboratories--

MLAB Revenue FAQ

What is Mesa Laboratories’s yearly revenue?

Mesa Laboratories's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $219.08M, representing an increase of 18.85% compared to 2022. MLAB's yearly revenue for 2022 was $184.34M, representing an increase of 37.63% compared to 2021.

What is Mesa Laboratories’s quarterly revenue?

Mesa Laboratories's quarterly revenue for Q1 2025 was $58.17M, a -1.25% decrease from the previous quarter (Q4 2024), and a 14.86% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $58.9M, a 10.16% increase from the previous quarter (Q3 2024), and a 5.96% increase year-over-year (Q4 2023). MLAB's quarterly revenue for Q3 2024 was $53.47M, a 0.58% increase from the previous quarter (Q2 2024), and a -1.50% decrease year-over-year (Q3 2023).

What is Mesa Laboratories’s revenue growth rate?

Mesa Laboratories's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Mesa Laboratories’s revenue streams?

Mesa Laboratories's revenue streams in r 24 are Clinical Genomics, Calibration Solutions, Sterilization and Disinfection Control, and Biopharmaceutical Development. Clinical Genomics generated $52.59M in revenue, accounting 24.33% of the company's total revenue Calibration Solutions generated $47.76M in revenue, accounting 22.09% of the company's total revenue Sterilization and Disinfection Control generated $75.12M in revenue, accounting 34.75% of the company's total revenue Biopharmaceutical Development generated $40.71M in revenue, accounting 18.83% of the company's total revenue

What is Mesa Laboratories’s main source of revenue?

For the fiscal year ending Mar 24, the largest source of revenue of Mesa Laboratories was Sterilization and Disinfection Control. This segment made a revenue of $75.12M, representing 34.75% of the company's total revenue.